Literature DB >> 29533362

Antipsychotic-Induced Pisa Syndrome: A 2-Year Follow-up Study.

Yen-Feng Lee.   

Abstract

OBJECTIVES: Pisa syndrome is characterized by lateral trunk flexion. It is an uncommon adverse drug reaction in patients on antipsychotic medication. Although Pisa syndrome has been reported in patients on antipsychotic treatment, previous studies have not discussed the prognosis of patients with Pisa syndrome. We studied psychiatric patients with Pisa syndrome following antipsychotic treatment for a 2-year period.
METHODS: From January 2012 to December 2014, 13 inpatients with Pisa syndrome following antipsychotic treatment were identified at our institution, from a prospectively collected database. These patients were studied for a 2-year period.
RESULTS: The prevalence rate of Pisa syndrome during neuroleptic treatment was 0.45% in men and 0.37% in women, with a collective prevalence rate of 0.42%. The mean age of patients with Pisa syndrome was 47 years. Eight (61.5%) of the cases had a position with a tilt toward the right side. In 5 (38.5%) of the cases, a tilt toward the left side was observed. The average Cobb angle of the trunk was 17.3 (SD, 4.0) degrees. On presentation with Pisa syndrome within 3 months of medication modification, the pattern of trunk dystonia had a significantly shorter duration (P = .024) compared with that seen in the tardive-onset group.
CONCLUSIONS: Pisa syndrome is an uncommon adverse event that can also be chronic or recurrent, especially in those with tardive onset. We should be aware of the risks in patients with the following predisposing factors: old age, chronic psychosis, long-term antipsychotic use, advanced drug-induced parkinsonism, and combined pharmacologic treatment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29533362     DOI: 10.1097/WNF.0000000000000274

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  2 in total

1.  Neurobiological mechanisms associated with antipsychotic drug-induced dystonia.

Authors:  Anton Jm Loonen; Svetlana A Ivanova
Journal:  J Psychopharmacol       Date:  2020-09-09       Impact factor: 4.153

Review 2.  Movement disorders in psychiatric patients.

Authors:  Laura Perju-Dumbrava; Peter Kempster
Journal:  BMJ Neurol Open       Date:  2020-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.